Showing results (831-840 of 1,516) with videos related to

Sort By:
Pageof 152
Targeted Oncology|June 15, 2014
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b studyIrene Brana, Antonio Calles, Patricia M LoRusso, et al.
Parkinsonism & Related Disorders|January 1, 1996
Changes induced by ovariectomy on the acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat poor metabolizer of debrisoquineF J Jiménez-Jiménez, M A Mena, J García-Agúndez, et al.
Cytometry|September 15, 1995
Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridizationM D Tabernero, J F San Miguel, J L Garcia, et al.
Neuro-Oncology|May 21, 2010
Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathologyAna Luísa Vital, Maria Dolores Tabernero, Abel Castrillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathologyAngel Maillo, Alberto Orfao, José María Sayagues, et al.
ESMO Open|August 27, 2022
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF<sup>wt</sup> metastatic colorectal cancerJ Tabernero, A Grothey, D Arnold, et al.
Central European Journal of Urology|September 24, 2014
Laparoscopic radical prostatectomy training for residents: Hospital Universitario La Paz modelSergio Alonso Y Gregorio, Juan Gómez Rivas, Susana Sánchez Molina, et al.
ESMO Open|March 12, 2024
Impact of KRAS<sup>G12</sup> mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trialJ Tabernero, J Taieb, M Fakih, et al.
Molecular Genetics and Genomics : MGG|March 17, 2011
Phylogenetic and genetic linkage between novel atypical dual-specificity phosphatases from non-metazoan organismsCarlos Romá-Mateo, Almudena Sacristán-Reviriego, Nicola J Beresford, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trialTakayuki Yoshino, Radka Obermannová, György Bodoky, et al.
Pageof 152